Skip to Primary Navigation

Skip to main content

FDA signals less regulation for wearable devices, AI providing non-medical information

A detailed view of a referee's Apple Watch.
Photo: Chris Tanouye/Freestyle Photography/Getty Images

Kevin Kinsella

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

According to new guidance, certain devices and software that track metrics such as heart rate and activity level will require less rigorous pre-market reviewal.

Through the issuance of two guidance documents on January 6, the US Food and Drug Administration (FDA) indicated it will limit the regulation of wearable devices that provide non-medical information as well as rules on clinical decision support software such as ChatGPT.

FDA Commissioner Marty Makary announced the new documents on

, , , , , , ,

Get full access, free for a month

Start your 28-day free trial to continue reading and access
all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience